GSK plc (GLAXF) stock
GLAXFOTCPharmaceutical PreparationsAlso trades as GSK
Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30
$24.74+0.30 (+1.21%)
Close on Oct 19, 2026Market cap $106.83BP/E 13.3Yield –
GSK gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 72.4%, against 71.2% the year before. The highest annual figure on record is 72.4% in fiscal 2025.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 72.4% | +1.2 |
| FY2024 | Dec 31, 2024 | 71.2% | −0.6 |
| FY2023 | Dec 31, 2023 | 71.8% | +4.3 |
| FY2022 | Dec 31, 2022 | 67.4% | +0.5 |
| FY2021 | Dec 31, 2021 | 66.9% | −0.5 |
| FY2020 | Dec 31, 2020 | 67.4% | +2.6 |
| FY2019 | Dec 31, 2019 | 64.9% | −1.9 |
| FY2018 | Dec 31, 2018 | 66.8% | +1.0 |
| FY2017 | Dec 31, 2017 | 65.7% | −1.0 |
| FY2016 | Dec 31, 2016 | 66.7% | +3.7 |
| FY2015 | Dec 31, 2015 | 63.0% | – |